Drugmakers Target China Waistlines With Public Campaigns
Weight-loss drugmakers in China are launching creative public awareness campaigns in metro stations and gyms to reach consumers. Strict advertising laws prevent direct prescription drug marketing, prompting companies to promote health education.
Xurve View
Insights:
Xurve View
Drugmakers are deploying subway banners, stadium ads, and fitness events across China to market weight-loss treatments, pushing the boundaries of local advertising restrictions. Sales of GLP-1 therapies in the region could surge to 30 billion yuan ($4 billion) over the next seven years. The aggressive outreach highlights intensifying competition among pharmaceutical giants in the world's second-largest drug market.
